CoChat
Sign Up
Cited by 167Traumatic Brain Injury and Neurovascular DisturbancesNeuroinflammation and Neurodegeneration MechanismsTraumatic Brain Injury Research

The DOI matches its Crossref record; 58 of the 58 references it cites were found in a registry or an index.

Macrophagic and microglial responses after focal traumatic brain injury in the female rat

Open access
Turtzo, L, Lescher, Jacob, Janes, Lindsay, Dean, Dana D, Budde, Matthew D, Frank, Joseph A·2014·Journal of Neuroinflammation
DOI 10.1186/1742-2094-11-82PMC PMC4022366
Open this paper in CoChat — free accountOpen PDF

Abstract

BACKGROUND: After central nervous system injury, inflammatory macrophages (M1) predominate over anti-inflammatory macrophages (M2). The temporal profile of M1/M2 phenotypes in macrophages and microglia after traumatic brain injury (TBI) in rats is unknown. We subjected female rats to severe controlled cortical impact (CCI) and examined the postinjury M1/M2 time course in their brains. METHODS: The motor cortex (2.5 mm left laterally and 1.0 mm anteriorly from the bregma) of anesthetized female Wistar rats (ages 8 to 10 weeks; N = 72) underwent histologically moderate to severe CCI with a 5-mm impactor tip. Separate cohorts of rats had their brains dissociated into cells for flow cytometry, perfusion-fixed for immunohistochemistry (IHC) and ex vivo magnetic resonance imaging or flash-frozen for RNA and protein analysis. For each analytical method used, separate postinjury times were included for 24 hours; 3 or 5 days; or 1, 2, 4 or 8 weeks. RESULTS: By IHC, we found that the macrophagic and microglial responses peaked at 5 to 7 days post-TBI with characteristics of mixed populations of M1 and M2 phenotypes. Upon flow cytometry examination of immunological cells isolated from brain tissue, we observed that peak M2-associated staining occurred at 5 days post-TBI. Chemokine analysis by multiplex assay showed statistically significant increases in macrophage inflammatory protein 1α and keratinocyte chemoattractant/growth-related oncogene on the ipsilateral side within the first 24 hours after injury relative to controls and to the contralateral side. Quantitative RT-PCR analysis demonstrated expression of both M1- and M2-associated markers, which peaked at 5 days post-TBI. CONCLUSIONS: The responses of macrophagic and microglial cells to histologically severe CCI in the female rat are maximal between days 3 and 7 postinjury. The response to injury is a mixture of M1 and M2 phenotypes.

Overview

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.1186/1742-2094-11-82

Cites

58 of 58 references verified0 citation errors · 0 not checkable

Statistics

Figures

Figure 1 Experimental design. Female Wistar rats (N = 72) underwent controlled cortical impact (CCI) to the left motor cortex on day 0. Their brains were harvested (n = 9 per time point) for immunohistochemistry (IHC), ex vivo magnetic resonance imaging (MRI), flow cytometry and RNA/protein analysis over a time course ranging from 1 day to 8 weeks postinjury. Naïve control rats were subjected to the same protocol.
Figure 1 Experimental design. Female Wistar rats (N = 72) underwent controlled cortical impact (CCI) to the left motor cortex on day 0. Their brains were harvested (n = 9 per time point) for immunohistochemistry (IHC), ex vivo magnetic resonance imaging (MRI), flow cytometry and RNA/protein analysis over a time course ranging from 1 day to 8 weeks postinjury. Naïve control rats were subjected to the same protocol.CC BY · PubMed Central
Figure 2 Evolution of controlled cortical impact injury over time.Ex vivo magnetic resonance imaging (MRI) and corresponding hematoxylin and eosin stains demonstrate the controlled cortical impact (CCI) lesion’s extension from the cortex through the corpus callosum. By 4 weeks postinjury, the lesion had evolved into a cavity, with minimal further changes observed by 8 weeks (data not shown). Arrowheads on day 1 MRI scans indicate areas of edema. The arrow on the day 7 scan indicates an area of hemorrhage.
Figure 2 Evolution of controlled cortical impact injury over time.Ex vivo magnetic resonance imaging (MRI) and corresponding hematoxylin and eosin stains demonstrate the controlled cortical impact (CCI) lesion’s extension from the cortex through the corpus callosum. By 4 weeks postinjury, the lesion had evolved into a cavity, with minimal further changes observed by 8 weeks (data not shown). Arrowheads on day 1 MRI scans indicate areas of edema. The arrow on the day 7 scan indicates an area of hemorrhage.CC BY · PubMed Central
Figure 3 Time course of inflammatory and anti-inflammatory macrophage markers in cells examined by flow cytometry. Cells that stained for markers associated with macrophagic and microglial phenotypes were detected by flow cytometry of cells isolated from the lesion and/or perilesion area. (A) and (B) Comparison of cells stained with (A) general macrophage marker CD68 and anti-inflammatory macrophage (M2)-associated marker CD163 and (B) CD68 versus inflammatory macrophage (M1)-associated marker CD40 demonstrates a change in population occurring between 3 days and 1 week postinjury. (C) Statistically significant changes in the percentage of cells relative to controls that stained positive for the M2-associated marker CD163 were detected at 3 and 5 days postinjury (CD163: control = 0.9 ± 0.2%, 3 days = 12 ± 3%, 5 days = 20 ± 2%; F = 55.70). No significant differences were observed regarding the percentages of cells that stained for CD40 and CD68 over the time course. *P < 0.05. (D) Normalization of CD40 or CD163 to CD68 for flow cytometry data at each time point relative to controls allows better visualization of the degree of changes in M1 versus M2 ratios of macrophages. Data for CD163 are statistically significant at 1, 3 and 5 days postinjury by one-way analysis of variance (CD163: control = 120 ± 30%, 1 day = 350 ± 20%, 3 days = 1,000 ± 100%, 5 days = 1,500 ± 100%; F = 92.61). Error bars indicate standard errors of the mean. *P < 0.05.
Figure 3 Time course of inflammatory and anti-inflammatory macrophage markers in cells examined by flow cytometry. Cells that stained for markers associated with macrophagic and microglial phenotypes were detected by flow cytometry of cells isolated from the lesion and/or perilesion area. (A) and (B) Comparison of cells stained with (A) general macrophage marker CD68 and anti-inflammatory macrophage (M2)-associated marker CD163 and (B) CD68 versus inflammatory macrophage (M1)-associated marker CD40 demonstrates a change in population occurring between 3 days and 1 week postinjury. (C) Statistically significant changes in the percentage of cells relative to controls that stained positive for the M2-associated marker CD163 were detected at 3 and 5 days postinjury (CD163: control = 0.9 ± 0.2%, 3 days = 12 ± 3%, 5 days = 20 ± 2%; F = 55.70). No significant differences were observed regarding the percentages of cells that stained for CD40 and CD68 over the time course. *P < 0.05. (D) Normalization of CD40 or CD163 to CD68 for flow cytometry data at each time point relative to controls allows better visualization of the degree of changes in M1 versus M2 ratios of macrophages. Data for CD163 are statistically significant at 1, 3 and 5 days postinjury by one-way analysis of variance (CD163: control = 120 ± 30%, 1 day = 350 ± 20%, 3 days = 1,000 ± 100%, 5 days = 1,500 ± 100%; F = 92.61). Error bars indicate standard errors of the mean. *P < 0.05.CC BY · PubMed Central
Figure 4 Immunohistochemistry of macrophagic and microglial markers in brain tissue after traumatic brain injury over time. Maximum immunofluorescence detection of markers of macrophagic and microglial polarization occurred by 5 days postinjury (DPI). (A) Representative anatomical localization of the regions of interest (ROIs; rectangles) quantified for the immunofluorescence of each marker. These ROIs were examined for the same anatomical slices from each animal. Scale bar = 3 mm. (B) Quantification of immunofluorescence in ROIs and representative immunofluorescent images at 1 DPI and 5 DPI. For a given time point, the column represents the average of all three ROIs for each slice, as shown in (A). Iba1, Ionized calcium-binding adapter molecule 1. Error bars indicate standard errors of the mean. *P < 0.05 for time point relative to 1 DPI. Scale bars = 100 μm.
Figure 4 Immunohistochemistry of macrophagic and microglial markers in brain tissue after traumatic brain injury over time. Maximum immunofluorescence detection of markers of macrophagic and microglial polarization occurred by 5 days postinjury (DPI). (A) Representative anatomical localization of the regions of interest (ROIs; rectangles) quantified for the immunofluorescence of each marker. These ROIs were examined for the same anatomical slices from each animal. Scale bar = 3 mm. (B) Quantification of immunofluorescence in ROIs and representative immunofluorescent images at 1 DPI and 5 DPI. For a given time point, the column represents the average of all three ROIs for each slice, as shown in (A). Iba1, Ionized calcium-binding adapter molecule 1. Error bars indicate standard errors of the mean. *P < 0.05 for time point relative to 1 DPI. Scale bars = 100 μm.CC BY · PubMed Central
Figure 5 Immunohistochemistry of macrophages double-labeled for CD68/CD86 or CD68/CD163. CD68-positive macrophages express CD86 and CD163. (A) Representative immunofluorescent images double-labeled for CD68/CD86 and 4′,6-diamidino-2-phenylindole (DAPI) at 1 day postinjury (DPI) and 5 DPI. CD68-positive macrophages expressing the M1 marker CD86 were located predominantly in necrotic tissue (white arrows). Similarly, macrophages expressing only CD86 were located in necrotic tissue (yellow arrows). Macrophages expressing only CD68 were located in non-necrotic perilesional tissue (red arrows). (B) Representative immunofluorescent images double-labeled for CD68/CD163 and DAPI at 1 DPI and 5 DPI. All CD68-positive macrophages were positive for CD163 to varying degrees (white arrows). The leftmost images in each row display low-magnification (4X) images (scale bars = 500 μm), with the rectangles indicating the selected areas of higher magnification (20X) (scale bars = 100 μm) shown in the three accompanying images to the right.
Figure 5 Immunohistochemistry of macrophages double-labeled for CD68/CD86 or CD68/CD163. CD68-positive macrophages express CD86 and CD163. (A) Representative immunofluorescent images double-labeled for CD68/CD86 and 4′,6-diamidino-2-phenylindole (DAPI) at 1 day postinjury (DPI) and 5 DPI. CD68-positive macrophages expressing the M1 marker CD86 were located predominantly in necrotic tissue (white arrows). Similarly, macrophages expressing only CD86 were located in necrotic tissue (yellow arrows). Macrophages expressing only CD68 were located in non-necrotic perilesional tissue (red arrows). (B) Representative immunofluorescent images double-labeled for CD68/CD163 and DAPI at 1 DPI and 5 DPI. All CD68-positive macrophages were positive for CD163 to varying degrees (white arrows). The leftmost images in each row display low-magnification (4X) images (scale bars = 500 μm), with the rectangles indicating the selected areas of higher magnification (20X) (scale bars = 100 μm) shown in the three accompanying images to the right.CC BY · PubMed Central
Figure 6 Time course of inflammatory macrophage– and anti-inflammatory macrophage–associated gene expression in the brain after traumatic brain injury. Changes in RNA expression of inflammatory macrophage (M1) and anti-inflammatory macrophage (M2) macrophagic and microglial markers peaked in ipsilateral brain tissue at 5 days postinjury (DPI) as assessed by quantitative RT-PCR. Statistically significant fold changes at 5 DPI relative to control and contralateral sides occurred for CD68, CD86, ionized calcium-binding adapter molecule 1 (Iba1) and mannose receptor, C type 1 (Mrc1). Changes in CD80 were significant when ipsilateral sides were compared to contralateral sides, but not in controls. In contrast, expression of tumor necrosis factor α (Tnf) was highest at 24 hours and 3 DPI, but there were no statistically significant fold changes in RNA expression of arginase 1 (Arg1), CD80, CD163 or nitric oxide synthase 2 (Nos2). Error bars indicate standard errors of the mean. *P < 0.05.
Figure 6 Time course of inflammatory macrophage– and anti-inflammatory macrophage–associated gene expression in the brain after traumatic brain injury. Changes in RNA expression of inflammatory macrophage (M1) and anti-inflammatory macrophage (M2) macrophagic and microglial markers peaked in ipsilateral brain tissue at 5 days postinjury (DPI) as assessed by quantitative RT-PCR. Statistically significant fold changes at 5 DPI relative to control and contralateral sides occurred for CD68, CD86, ionized calcium-binding adapter molecule 1 (Iba1) and mannose receptor, C type 1 (Mrc1). Changes in CD80 were significant when ipsilateral sides were compared to contralateral sides, but not in controls. In contrast, expression of tumor necrosis factor α (Tnf) was highest at 24 hours and 3 DPI, but there were no statistically significant fold changes in RNA expression of arginase 1 (Arg1), CD80, CD163 or nitric oxide synthase 2 (Nos2). Error bars indicate standard errors of the mean. *P < 0.05.CC BY · PubMed Central
Figure 7 Temporal changes in cytokine RNA expression in the brain after traumatic brain injury. RNA expression of pro- and anti-inflammatory cytokines in ipsilateral brain changes in the first days to 8 weeks after injury. Initial fold changes were detected using pooled samples for each time point in a rat cytokine array. Fold changes greater than fourfold relative to baseline were subsequently verified in custom arrays by running individual samples in triplicate for each time point. Maximum fold changes were occurred for interleukin 1β (Il1β), IL-11 (Il11) and chemokine (C-X-C motif) ligand 1 (Cxcl1) at 24 hours postinjury. Maximum fold changes occurred for colony-stimulating factor 1 (Csf1) 3 to 5 days postinjury, IL-18 (Il18) peaked at 5 days postinjury and IL-1 receptor antagonist (IL-1rn) was elevated from 24 hours to 5 days postinjury. Error bars indicate standard errors of the mean. *P < 0.05.
Figure 7 Temporal changes in cytokine RNA expression in the brain after traumatic brain injury. RNA expression of pro- and anti-inflammatory cytokines in ipsilateral brain changes in the first days to 8 weeks after injury. Initial fold changes were detected using pooled samples for each time point in a rat cytokine array. Fold changes greater than fourfold relative to baseline were subsequently verified in custom arrays by running individual samples in triplicate for each time point. Maximum fold changes were occurred for interleukin 1β (Il1β), IL-11 (Il11) and chemokine (C-X-C motif) ligand 1 (Cxcl1) at 24 hours postinjury. Maximum fold changes occurred for colony-stimulating factor 1 (Csf1) 3 to 5 days postinjury, IL-18 (Il18) peaked at 5 days postinjury and IL-1 receptor antagonist (IL-1rn) was elevated from 24 hours to 5 days postinjury. Error bars indicate standard errors of the mean. *P < 0.05.CC BY · PubMed Central
Figure 8 Changes in cytokine and chemokine protein expression after traumatic brain injury. The fold change protein expression of cytokines and growth factors assessed by multiplex assay decreased relative to expression in naïve controls in the combined lesion/perilesion area after injury, as summarized in the accompanying heat map. Chemokines macrophage inflammatory protein 1α (MIP-1a) and keratinocyte chemoattractant/growth-related oncogene (GRO KC) were the only proteins observed to have increased over the time course, peaking at 24 hours after injury, then decreasing. EPO, Erythropoietin; G-CSF, Granulocyte colony-stimulating factor; GM-CSF, Granulocyte-macrophage colony-stimulating factor; IFN-g, Interferon γ; IL, Interleukin; M-CSF, Macrophage colony-stimulating factor; RANTES, Regulated on activation, normal T cell expressed and secreted; TNF, Tumor necrosis factor; VEGF, Vascular endothelial growth factor. *P < 0.05.
Figure 8 Changes in cytokine and chemokine protein expression after traumatic brain injury. The fold change protein expression of cytokines and growth factors assessed by multiplex assay decreased relative to expression in naïve controls in the combined lesion/perilesion area after injury, as summarized in the accompanying heat map. Chemokines macrophage inflammatory protein 1α (MIP-1a) and keratinocyte chemoattractant/growth-related oncogene (GRO KC) were the only proteins observed to have increased over the time course, peaking at 24 hours after injury, then decreasing. EPO, Erythropoietin; G-CSF, Granulocyte colony-stimulating factor; GM-CSF, Granulocyte-macrophage colony-stimulating factor; IFN-g, Interferon γ; IL, Interleukin; M-CSF, Macrophage colony-stimulating factor; RANTES, Regulated on activation, normal T cell expressed and secreted; TNF, Tumor necrosis factor; VEGF, Vascular endothelial growth factor. *P < 0.05.CC BY · PubMed Central

Verification

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Citations

Cites

Show all 58 references

Cited by

Sorted by citations

Related

See all

Metadata

Authors
Turtzo, L., Lescher, J., Janes, L., Dean, D. D., Budde, M. D., & Frank, J. A.
Affiliations
  • Uniformed Services University of the Health Sciences (US)
  • National Institutes of Health (US)
Corresponding author
Turtzo, L
ORCID
Venue
Journal of Neuroinflammation
Publisher
Springer Science and Business Media LLC
Published
2014
Volume
11
Issue
1
Pages
82
ISSN
1742-2094 (ISSN-L)
DOI
10.1186/1742-2094-11-82
PMC
PMC4022366
OpenAlex
W2157968665
Cited by
167
References
58
Citations by year
2026: 5 · 2025: 11 · 2024: 9 · 2023: 6 · 2022: 8 · 2021: 16 · 2020: 16 · 2019: 20 · 2018: 12 · 2017: 24 · 2016: 16 · 2015: 20 · 2014: 3
FWCI
13.69
Type
journal article
Language
en
Open access
Licence
cc-by
Locations
  • Journal of Neuroinflammation (publishedVersion, cc-by)
  • Europe PMC (PubMed Central) (publishedVersion, cc-by)
  • PubMed Central (publishedVersion, cc-by)
  • PubMed (publishedVersion)
Funders
  • U.S. Department of Defense
  • Henry M. Jackson Foundation
  • National Institutes of Health
  • U.S. Public Health Service (01-60855)
  • Center for Neuroscience and Regenerative Medicine (60855)
Topics
  • Health Sciences › Medicine › Clinical Neurology › Traumatic Brain Injury and Neurovascular Disturbances
  • Life Sciences › Neuroscience › Neurology › Neuroinflammation and Neurodegeneration Mechanisms
  • Health Sciences › Medicine › Clinical Neurology › Traumatic Brain Injury Research
Keywords
traumatic brain injury, macrophage polarization, M1/M2 macrophages, microglia, controlled cortical impact, female rats, neuroinflammation, chemokines, CCL17, CCL22, motor cortex
MeSH terms
Analysis of Variance, Animals, Brain, Brain Injuries, Calcium-Binding Proteins, Disease Models, Animal, Female, Flow Cytometry, Gene Expression Regulation, Macrophages, Magnetic Resonance Imaging, Microfilament Proteins, Microscopy, Fluorescence, Time Factors, Cytokines, Rats, Wistar, Microglia, Rats

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review